Shopping Cart
- Remove All
- Your shopping cart is currently empty
GprA, a novel synthetic agonist for G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 (GPR120/FFAR4), demonstrates an AC50 of 203 nM on the full-length human GPR120 isoform. It is valuable for research into non-alcoholic fatty liver disease (NAFLD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | GprA, a novel synthetic agonist for G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 (GPR120/FFAR4), demonstrates an AC50 of 203 nM on the full-length human GPR120 isoform. It is valuable for research into non-alcoholic fatty liver disease (NAFLD). |
In vivo | GprA effectively reduces signs of fatty degeneration in mice fed with a Western-style diet (WSD). It also plays a significant role in decreasing collagen deposition and the progression of fibrosis. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.